Gunars Gaikis

Gunars Gaikis

Key Details

Gunars Gaikis
Partner
Smart & Biggar
Canada

  • Biotech
  • Biotechnology
  • Life Sciences
  • Patents
  • Pharmaceutical
  • Technology
  • Trademark

Overview

Gunars Gaikis is a pre-eminent and pioneering leader in life sciences IP. He has particularly focused on patent, regulatory and trademark-related litigation for pharmaceutical and biotechnology companies. Gunars has been at the forefront of the pharmaceutical patent litigation field since its emergence in the early 1990s. He has had numerous publications on matters related to his practice.

Participation in Wider Community

  • "Clarification of the 'promise' of utility doctrine in Canada," Expert Guides: Patent 2015, March 2015, pp. 88-89
  • "The race for market exclusivity," Life Sciences Intellectual Property Review Quarterly, Vol. 2, Issue 2 (2015)
  • "Cold Feet in Canada," Life Sciences Intellectual Property Review Quarterly, Vol. 2, Issue 1 (2015)
  • "Supreme Court of Canada: VIAGRA patent "void" for insufficient disclosure" (co-authors: J. Sheldon Hamilton and Colin B. Ingram), IP Update — Canada, November 8, 2012
  • "Pharmaceutical Patent Litigation is Inevitable — Typically Overlooked Licensing Terms" (co-authors: Junyi Chen, Jeff J. Kang and Rebecca B. Rodal), presented at the Federated Press conference titled "Negotiating & Drafting Bio Pharma Contracts," June 2011

Professional Affiliations

  • Fellow, Intellectual Property Institute of Canada
  • Member, Pharmaceutical Trade Marks Group
  • Member, American Intellectual Property Law Association
  • Past long-time Chair of the Patent Committee of the IP Section, Canadian Bar Association
  • Editorial board member of LSIPR Newsletter

Academic Affiliations

  • "Navigating Jurisdictional Challenges and Quantifying Damages in s. 8 Cases: Critical Views from Both Sides" panel discussion at the Canadian Institute's 11th Annual Forum on Pharma Patents, Toronto, October 2012
  • "Damages in Patent Infringement and Section 8 Cases: The View from Both Sides" panel discussion at the Canadian Institute's 10th Annual Forum on Pharma Patents, Toronto, October 2011
  • "Strategies in Pharma Patent Litigation," Insight Information's 9th conference on Drug Patents in Canada, Toronto, May 2010
  • "Pharma Patents Litigation: Year in Review," panel discussion at The Canadian Institute's 8th Annual Forum on Pharma Patents, Toronto, October 2009
  • "Pharma Patent Trials Within Two Years," Insight Information's Drug Patent and Legal Forum, Toronto, May 2009

WIPR